You searched for "Dundee"
Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.Simulating the visual impairment symptoms of age-related macular degeneration in virtual reality
5 June 2023
| Cameron R M Wilson, Ian Underwood, Baljean Dhillon (Prof)
|
EYE - Vitreo-Retinal
A new virtual reality application visually simulates age-related macular degeneration and demonstrates its progression over time including some Charles Bonnet syndrome hallucinations. Introduction Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries with the prevalence of...
Leber’s hereditary optic neuropathy: from lab to clinic
1 October 2016
| Chrysostomos D Dimitriou
|
EYE - Neuro-ophthalmology
|
Hereditary optic neuropathy, Leber hereditary optic neuropathy, mitochondrial optic neuropathy, optic neuropathy
Leber’s hereditary optic neuropathy (LHON) was the first clinically described mitochondrial disorder (1871). This article reviews the pathophysiology and clinical features of LHON with a focus on translational research. G11778A is currently the most common mutation worldwide and is associated...
Papilloedema: an update
1 June 2016
| James F (Barry) Cullen
|
EYE - Neuro-ophthalmology
Some readers may have seen a recent report in the national newspapers of the case of a teenage girl with persistent severe headache associated with a fatal brain tumour having been undiagnosed despite many consultations with her medical advisers. It...
High quality retinal image grading and management service by the NetwORC UK
1 October 2016
| Rahila Bashir
|
EYE - Imaging
In 2004 a network of three ophthalmic reading centres in Belfast, London and Liverpool (known as NetwORC UK) was established to form the largest reading centre in Europe for the purpose of providing high quality grading of ophthalmic images for...
Stars in their eyes!
3 February 2023
| Rahila Bashir
|
EYE - General
The year 2022 was a wonderful experience of travelling through starry nights, when passing by the beaches of Tel Aviv by road, flying over the Swiss Alps in Switzerland by air and walking through the Sand Dunes and streets of...
Burnout: ubiquitous and unavoidable?
3 August 2023
| Meriam Islam
|
EYE - General
Meriam Islam reminds us of the importance of ‘putting our oxygen mask on first’ and avoiding burnout while we progress through our careers. Burnout. It’s a term we hear a lot. What does it mean though? According to Merriam Webster,...
Uveal melanoma
3 August 2023
| Mertcan Sevgi, Timothy Beckman, Paul Cauchi, Julie Connolly, Vikas Chadha
|
EYE - Pathology, EYE - Oncology, EYE - Imaging
Uveal melanoma is the most common primary intraocular tumour. However, they are still rare, with an incidence of 2-8 per million [1]. The presence of a choroidal naevus is a risk factor for uveal melanoma [1]. Patients with choroidal lesions...
Hospital wins funding to investigate sickle cell sight loss.
12 July 2023
The hospital trust is the first in the UK to lead on a research project to understand the impact of sickle cell disease on eyesight.
The College of Optometrists welcomes recommendations to increase support for NHS eyecare costs
Sarah Cant, Director of Policy and Strategy, The College of Optometrists, commented: “The College of Optometrists welcomes Healthwatch England’s recommendations to increase the support available for people on low incomes so that they can meet the costs of eyecare, a...Retinoblastoma management update (part 2): treatment, screening and surveillance, long-term follow-up and new developments
1 February 2017
| Manoj V Parulekar
|
EYE - Oncology
Retinoblastoma treatment requires significant multidisciplinary input, but early detection through raising awareness remains key to improving outcomes. In the second article of a two-part series, Manoj Parulekar discusses retinoblastoma management, screening and research. This article has been published in two...
Crystalline keratopathy in monoclonal gammopathy of undetermined significance
2 April 2025
| Kar Yen Phoong
|
EYE - Cornea
Monoclonal gammopathies encompass a group of plasma cell disorders characterised by the excessive production of abnormal monoclonal immunoglobulins in the bloodstream [1]. This category includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), amyloidosis and other lymphoproliferative disorders. Monoclonal gammopathy...
